These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3865246)

  • 1. A modified dexamethasone suppression test for endogenous depression.
    Poland RE; Rubin RT; Lane LA; Martin DJ; Rose DE; Lesser IM
    Psychiatry Res; 1985 Aug; 15(4):293-9. PubMed ID: 3865246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls.
    Hunt GE; O'Sullivan BT; Johnson GF; Caterson ID
    Psychiatry Res; 1991 Feb; 36(2):209-22. PubMed ID: 2017535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT; Hunt GE; Johnson GF; Caterson ID
    Biol Psychiatry; 1989 Mar; 25(6):739-54. PubMed ID: 2923936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lower limits of dexamethasone window in Chinese depressives.
    Shiah IS; Ko HC; Lu RB
    Biol Psychiatry; 1998 Oct; 44(7):648-55. PubMed ID: 9787892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine aspects of primary endogenous depression: VI. Receiver operating characteristic analysis of the cortisol suppression index versus the dexamethasone suppression test in patients and matched controls.
    McCracken JT; Rubin RT; Poland RE
    Psychiatry Res; 1988 Oct; 26(1):69-78. PubMed ID: 3237907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
    Thompson LM; Rubin RT; McCracken JT
    Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine aspects of primary endogenous depression: IX. Receiver operating characteristic analysis of the dexamethasone suppression index vs. the dexamethasone suppression test in patients and controls.
    McCracken JT; Rubin RT; Poland RE
    Psychiatry Res; 1990 Jan; 31(1):49-56. PubMed ID: 2315422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone kinetics in depressed patients before and after clinical response.
    Maguire KP; Tuckwell VM; Schweitzer I; Tiller JW; Davies BM
    Psychoneuroendocrinology; 1990; 15(2):113-23. PubMed ID: 2359809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the cortisol suppression index and the dexamethasone suppression test.
    Laux G; Schlesser MA; Rush AJ; Orsulak P; Weissenburger J
    J Clin Psychiatry; 1984 Oct; 45(10):431-2. PubMed ID: 6480568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E; Eskola J; Ruuskanen O; Laine T
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):413-22. PubMed ID: 4070644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dex/CRH test--is it better than the DST?
    Watson S; Gallagher P; Smith MS; Ferrier IN; Young AH
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and cortisol suppression by dexamethasone in normal subjects.
    Weiner MF
    J Psychiatr Res; 1989; 23(2):163-8. PubMed ID: 2585347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men.
    Avgerinos PC; Kiamouris CK; Petrakos IP; Kleanthous IK; Zorzos PA; Dimitriadis TN; Raptis SA; Cutler GB
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1358-61. PubMed ID: 1331166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DST in depression is unaffected by altering the clock time of its administration.
    Pepper GM; Davis KL; Davis BM; Krieger DT
    Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B; Sherman B; Schlechte J; Stone R
    Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics.
    Holsboer F; Wiedemann K; Gerken A; Boll E
    Psychiatry Res; 1986 Feb; 17(2):97-103. PubMed ID: 3961034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.